Trials / Unknown
UnknownNCT05570487
RESECTED LYMPH NODES AND SURVIVAL OF PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA: AN OBSERVATIONAL STUDY
Increasing the Number of Resected Lymph Nodes Improves Overall Survival of Patients With Esophageal Squamous Cell Carcinoma With Positive Lymph Nodes: a Retrospective Analysis of 1656 Cases at a Single Cancer Center
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,600 (estimated)
- Sponsor
- Yongtao Han · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
To clarify the effect of the number of lymph node dissection and the number of stations on survival
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Since the data were collected retrospectively, there were no interventions | Since the data were collected retrospectively, there were no interventions |
Timeline
- Start date
- 2022-10-01
- Primary completion
- 2022-12-01
- Completion
- 2023-10-01
- First posted
- 2022-10-06
- Last updated
- 2022-10-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05570487. Inclusion in this directory is not an endorsement.